VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3664
+0.0198 (5.71%)
At close: Oct 30, 2025, 4:00 PM EDT
0.3730
+0.0066 (1.80%)
Pre-market: Oct 31, 2025, 4:32 AM EDT
VYNE Therapeutics Stock Forecast
VYNE's stock price has decreased by -86.38% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for VYNE Therapeutics stock has a target of 8.00, which predicts a 2,083.41% increase from the current stock price of 0.37.
Price Target: $8.00 (+2,083.41%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 18, 2024.
Analyst Ratings
The average analyst rating for VYNE Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5.75 → $4.5 | Strong Buy | Maintains | $5.75 → $4.5 | +1,128.17% | Apr 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +1,469.32% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +1,469.32% | Feb 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5.75 | Strong Buy | Reiterates | $5.75 | +1,469.32% | Jan 14, 2025 |
Financial Forecast
Revenue This Year
204.00K
from 501.00K
Decreased by -59.28%
Revenue Next Year
153.00K
from 204.00K
Decreased by -25.00%
EPS This Year
-0.71
from -0.94
EPS Next Year
-0.86
from -0.71
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 420,000 | 315,000 | |||
| Avg | 204,000 | 153,000 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -16.2% | 54.4% | |||
| Avg | -59.3% | -25.0% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.61 | -0.62 | |||
| Avg | -0.71 | -0.86 | |||
| Low | -0.87 | -1.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.